Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model

The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25% and has continued to increase; however, no drugs have yet been approved for NAFLD treatments. The ethyl acetate fraction of Amomum xanthioides (EFAX) was previously reported to have an anti-hepatic fibrosis effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Im, Hwi-Jin, Hwang, Seung-Ju, Lee, Jin-Seok, Lee, Sung-Bae, Kang, Ji-Yun, Son, Chang-Gue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468949/
https://www.ncbi.nlm.nih.gov/pubmed/32823613
http://dx.doi.org/10.3390/nu12082433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468949/
https://www.ncbi.nlm.nih.gov/pubmed/32823613
http://dx.doi.org/10.3390/nu12082433

Ejemplares similares